Induction Preoperative Chemotherapy for Patients With Locally Advanced Triple Negative Breast Cancer

NCT01969032 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

41

Enrollment

OTHER

Sponsor class

Conditions

Triple Negative Breast Cancer

Interventions

DRUG: Paclitaxel, Carboplatinum, Doxorubicin, Endoxan, Capecitabine

Sponsor

Russian Academy of Medical Sciences